Gastric Bypass After Previous Anti-reflux Surgery

Completed

Conditions studied: Clinically Severe Obesity, Gastroesophageal Reflux Disease

In brief

The goal of this study is to describe the clinical presentation, indications, and operative treatment as well as assess the morbidity, mortality, and overall performance of revisional Roux-en-Y gastric bypass (RYGB) after either failed or functional antireflux surgery "ARS" in obese patients. With such information, we hope to determine which features might assist us in advancing our knowledge about Gastro-Esophageal Reflux Disease "GERD", the best option for primary ARS, and mechanisms of failure in the obese population as well as in identifying predictors of outcome after revisional surgery in this population.

Key facts

Study ID

NCT01041105

Run by

University of California, San Francisco

People needed

22

Starts

2008-12-01

Expected to finish

2009-12-01

Last updated by the study team

2010-01-01

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Status post, either open or laparoscopic, primary Nissen fundoplication with all the following requirements:
• Met NIH criteria for bariatric surgery
• With functional or failed antireflux surgery (Nissen fundoplication)
• Laparoscopic approach for revisional surgery

You may not qualify if…

• Any other type of revisional bariatric procedure
• Nonstandard revisional RYGB surgery
• Open approach for revision surgery
• Missing records and/or unreachable patients with scant information for analysis

Where it is running

• UCSF Fresno Center for Medical Education and Research — Fresno, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.